Apontis Pharma AG (APPH) — Cash Flow Quality Index
Apontis Pharma AG (APPH) has a Cash Flow Quality Index of -3.22x as of June 2025. Operating cash flow of €-1.94 Million is below net income of €603.75K, suggesting accrual-heavy earnings not yet converted to cash. Explore Apontis Pharma AG cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Apontis Pharma AG Cash Flow Quality Index (2022–2024)
Historical Cash Flow Quality Index for Apontis Pharma AG across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check APPH cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Apontis Pharma AG (2022–2024)
Year-by-year earnings quality comparison for Apontis Pharma AG. For live market cap and the full company financial profile, see market value of Apontis Pharma AG.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -3.85x | €-2.90 Million | €753.57K | ▼ -193.9% |
| 2022 | 4.10x | €11.02 Million | €2.69 Million | — |